| Year |
Citation |
Score |
| 2023 |
Scherrer KH, Eans SO, Medina JM, Senadheera SN, Khaliq T, Murray TF, McLaughlin JP, Aldrich JV. Tryptophan Substitution in CJ-15,208 ([Phe-D-Pro-Phe-Trp]) Introduces δ-Opioid Receptor Antagonism, Preventing Antinociceptive Tolerance and Stress-Induced Reinstatement of Extinguished Cocaine-Conditioned Place Preference. Pharmaceuticals (Basel, Switzerland). 16. PMID 37765026 DOI: 10.3390/ph16091218 |
0.788 |
|
| 2022 |
Brice-Tutt AC, Eans SO, Yakovlev D, Aldrich JV, McLaughlin JP. An analog of [d-Trp]CJ-15,208 exhibits kappa opioid receptor antagonism following oral administration and prevents stress-induced reinstatement of extinguished morphine conditioned place preference. Pharmacology, Biochemistry, and Behavior. 217: 173405. PMID 35584724 DOI: 10.1016/j.pbb.2022.173405 |
0.768 |
|
| 2021 |
Zhao Y, Joshi AA, Aldrich JV, Murray TF. Quantification of kappa opioid receptor ligand potency, efficacy and desensitization using a real-time membrane potential assay. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 143: 112173. PMID 34536757 DOI: 10.1016/j.biopha.2021.112173 |
0.591 |
|
| 2021 |
Aldrich JV, McLaughlin JP. Peptide Kappa Opioid Receptor Ligands and Their Potential for Drug Development. Handbook of Experimental Pharmacology. PMID 34463847 DOI: 10.1007/164_2021_519 |
0.787 |
|
| 2021 |
Gisemba SA, Ferracane MJ, Murray TF, Aldrich JV. Conformational Constraint between Aromatic Residue Side Chains in the "Message" Sequence of the Peptide Arodyn Using Ring Closing Metathesis Results in a Potent and Selective Kappa Opioid Receptor Antagonist. Journal of Medicinal Chemistry. PMID 33688737 DOI: 10.1021/acs.jmedchem.0c01984 |
0.635 |
|
| 2020 |
Brice-Tutt AC, Senadheera SN, Ganno ML, Eans SO, Khaliq T, Murray TF, McLaughlin JP, Aldrich JV. Phenylalanine Stereoisomers of CJ-15,208 and [d-Trp]CJ-15,208 Exhibit Distinctly Different Opioid Activity Profiles. Molecules (Basel, Switzerland). 25. PMID 32887303 DOI: 10.3390/Molecules25173999 |
0.78 |
|
| 2020 |
Brice-Tutt AC, Wilson LL, Eans SO, Stacy HM, Simons CA, Simpson GG, Coleman JS, Ferracane MJ, Aldrich JV, McLaughlin JP. Multifunctional Opioid Receptor Agonism and Antagonism by a Novel Macrocyclic Tetrapeptide Prevents Reinstatement of Morphine-Seeking Behavior. British Journal of Pharmacology. PMID 32562259 DOI: 10.1111/Bph.15165 |
0.778 |
|
| 2020 |
Ferracane MJ, Brice-Tutt A, Coleman J, Simpson G, Wilson L, Eans SO, Stacy H, Murray TF, McLaughlin JP, Aldrich JV. Design, Synthesis, and Characterization of the Macrocyclic Tetrapeptide [Pro-Sar-Phe-D-Phe]: a Mixed Opioid Receptor Agonist-Antagonist Following Oral Administration. Acs Chemical Neuroscience. PMID 32251585 DOI: 10.1021/Acschemneuro.0C00086 |
0.774 |
|
| 2019 |
Gisemba SA, Aldrich JV. Optimized Ring Closing Metathesis Reaction Conditions to Suppress Desallyl Side Products in the Solid Phase Synthesis of Cyclic Peptides involving Tyrosine(O-allyl). The Journal of Organic Chemistry. PMID 31880448 DOI: 10.1021/acs.joc.9b02345 |
0.474 |
|
| 2017 |
Fang WJ, Murray TF, Aldrich JV. Design, synthesis, and opioid activity of arodyn analogs cyclized by ring-closing metathesis involving Tyr(allyl). Bioorganic & Medicinal Chemistry. PMID 29273415 DOI: 10.1016/j.bmc.2017.11.029 |
0.789 |
|
| 2017 |
Joshi AA, Murray TF, Aldrich JV. Alanine scan of the opioid peptide dynorphin B amide. Biopolymers. PMID 28464209 DOI: 10.1002/bip.23026 |
0.565 |
|
| 2016 |
Khaliq T, Williams TD, Senadheera SN, Aldrich JV. Development of a robust, sensitive and selective liquid chromatography-tandem mass spectrometry assay for the quantification of the novel macrocyclic peptide kappa opioid receptor antagonist [D-Trp]CJ-15,208 in plasma and application to an initial pharmacokinetic study. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 1028: 11-15. PMID 27318293 DOI: 10.1016/J.Jchromb.2016.05.043 |
0.354 |
|
| 2016 |
Sirohi S, Aldrich JV, Walker BM. Species differences in the effects of the κ-opioid receptor antagonist zyklophin. Alcohol (Fayetteville, N.Y.). 51: 43-9. PMID 26992699 DOI: 10.1016/J.Alcohol.2015.11.012 |
0.328 |
|
| 2016 |
Huang P, Yakovleva T, Aldrich JV, Tunis J, Parry C, Liu-Chen LY. Two short-acting kappa opioid receptor antagonists (zyklophin and LY2444296) exhibited different behavioral effects from the long-acting antagonist norbinaltorphimine in mouse anxiety tests. Neuroscience Letters. PMID 26780565 DOI: 10.1016/J.Neulet.2016.01.017 |
0.419 |
|
| 2015 |
Joshi A, Murray TF, Aldrich JV. Structure-Activity Relationships of the Peptide Kappa Opioid Receptor Antagonist Zyklophin. Journal of Medicinal Chemistry. PMID 26491810 DOI: 10.1021/jm501827k |
0.525 |
|
| 2014 |
Aldrich JV, Senadheera SN, Ross NC, Reilley KA, Ganno ML, Eans SE, Murray TF, McLaughlin JP. Alanine analogues of [D-Trp]CJ-15,208: novel opioid activity profiles and prevention of drug- and stress-induced reinstatement of cocaine-seeking behaviour. British Journal of Pharmacology. 171: 3212-22. PMID 24588614 DOI: 10.1111/Bph.12664 |
0.727 |
|
| 2014 |
Dimattio KM, Yakovleva TV, Aldrich JV, Cowan A, Liu-Chen LY. Zyklophin, a short-acting kappa opioid antagonist, induces scratching in mice. Neuroscience Letters. 563: 155-9. PMID 24503508 DOI: 10.1016/J.Neulet.2014.01.022 |
0.397 |
|
| 2014 |
Eans S, Ganno M, Mizrachi E, Senadheera S, Aldrich J, McLaughlin JP. Development of mixed opioid agonist/antagonists to prevent reinstatement of extinguished cocaine-seeking behavior Drug and Alcohol Dependence. 140: e53-e54. DOI: 10.1016/J.Drugalcdep.2014.02.166 |
0.706 |
|
| 2013 |
Eans SO, Ganno ML, Reilley KJ, Patkar KA, Senadheera SN, Aldrich JV, McLaughlin JP. The macrocyclic tetrapeptide [D-Trp]CJ-15,208 produces short-acting κ opioid receptor antagonism in the CNS after oral administration. British Journal of Pharmacology. 169: 426-36. PMID 23425081 DOI: 10.1111/Bph.12132 |
0.743 |
|
| 2013 |
Zhou Y, Leri F, Grella SL, Aldrich JV, Kreek MJ. Involvement of dynorphin and kappa opioid receptor in yohimbine-induced reinstatement of heroin seeking in rats. Synapse (New York, N.Y.). 67: 358-61. PMID 23345075 DOI: 10.1002/Syn.21638 |
0.445 |
|
| 2013 |
Aldrich JV, Senadheera SN, Ross NC, Ganno ML, Eans SO, McLaughlin JP. The macrocyclic peptide natural product CJ-15,208 is orally active and prevents reinstatement of extinguished cocaine-seeking behavior. Journal of Natural Products. 76: 433-8. PMID 23327691 DOI: 10.1021/Np300697K |
0.669 |
|
| 2012 |
Aldrich JV, McLaughlin JP. Opioid Peptides: Potential for Drug Development. Drug Discovery Today. Technologies. 9: e23-e31. PMID 23316256 DOI: 10.1016/J.Ddtec.2011.07.007 |
0.762 |
|
| 2012 |
Sloan CD, Audus KL, Aldrich JV, Lunte SM. The permeation of dynorphin A 1-6 across the blood brain barrier and its effect on bovine brain microvessel endothelial cell monolayer permeability. Peptides. 38: 414-7. PMID 23046728 DOI: 10.1016/J.Peptides.2012.09.031 |
0.333 |
|
| 2012 |
Ross NC, Reilley KJ, Murray TF, Aldrich JV, McLaughlin JP. Novel opioid cyclic tetrapeptides: Trp isomers of CJ-15,208 exhibit distinct opioid receptor agonism and short-acting κ opioid receptor antagonism. British Journal of Pharmacology. 165: 1097-108. PMID 21671905 DOI: 10.1111/J.1476-5381.2011.01544.X |
0.781 |
|
| 2011 |
Fang WJ, Yakovleva T, Aldrich JV. A convenient approach to synthesizing peptide C-terminal N-alkyl amides. Biopolymers. 96: 715-22. PMID 22252422 DOI: 10.1002/Bip.21600 |
0.593 |
|
| 2011 |
Aldrich JV, Kulkarni SS, Senadheera SN, Ross NC, Reilley KJ, Eans SO, Ganno ML, Murray TF, McLaughlin JP. Unexpected opioid activity profiles of analogues of the novel peptide kappa opioid receptor ligand CJ-15,208. Chemmedchem. 6: 1739-45. PMID 21761566 DOI: 10.1002/Cmdc.201100113 |
0.751 |
|
| 2011 |
Kelamangalath L, Dravid SM, George J, Aldrich JV, Murray TF. κ-Opioid receptor inhibition of calcium oscillations in spinal cord neurons. Molecular Pharmacology. 79: 1061-71. PMID 21422300 DOI: 10.1124/Mol.111.071456 |
0.38 |
|
| 2011 |
Fang WJ, Bennett MA, Aldrich JV. Deletion of Ac-NMePhe(1) from [NMePhe(1) ]arodyn under acidic conditions, part 1: effects of cleavage conditions and N-terminal functionality. Biopolymers. 96: 97-102. PMID 20560149 DOI: 10.1002/Bip.21496 |
0.684 |
|
| 2011 |
Fang WJ, Bennett MA, Murray TF, Aldrich JV. Deletion of Ac-NMePhe(1) from [NMePhe(1) ]arodyn under acidic conditions, part 2: effects of substitutions on pharmacological activity. Biopolymers. 96: 103-10. PMID 20560148 DOI: 10.1002/Bip.21495 |
0.774 |
|
| 2010 |
Ross NC, Kulkarni SS, McLaughlin JP, Aldrich JV. Synthesis of CJ-15,208, a novel κ-opioid receptor antagonist. Tetrahedron Letters. 51: 5020-5023. PMID 22865937 DOI: 10.1016/J.Tetlet.2010.07.086 |
0.676 |
|
| 2009 |
Aldrich JV, Patkar KA, McLaughlin JP. Zyklophin, a systemically active selective kappa opioid receptor peptide antagonist with short duration of action. Proceedings of the National Academy of Sciences of the United States of America. 106: 18396-401. PMID 19841255 DOI: 10.1073/Pnas.0910180106 |
0.749 |
|
| 2009 |
Patkar KA, Murray TF, Aldrich JV. The effects of C-terminal modifications on the opioid activity of [N-benzylTyr(1)]dynorphin A-(1-11) analogues. Journal of Medicinal Chemistry. 52: 6814-21. PMID 19807094 DOI: 10.1021/Jm900715M |
0.582 |
|
| 2009 |
Fang WJ, Cui Y, Murray TF, Aldrich JV. Design, synthesis, and pharmacological activities of dynorphin A analogues cyclized by ring-closing metathesis. Journal of Medicinal Chemistry. 52: 5619-25. PMID 19715279 DOI: 10.1021/Jm900577K |
0.756 |
|
| 2009 |
Sinha B, Cao Z, Murray TF, Aldrich JV. Discovery of dermorphin-based affinity labels with subnanomolar affinity for mu opioid receptors. Journal of Medicinal Chemistry. 52: 7372-5. PMID 19621878 DOI: 10.1021/Jm9007592 |
0.732 |
|
| 2009 |
Aldrich JV, McLaughlin JP. Peptide kappa opioid receptor ligands: potential for drug development. The Aaps Journal. 11: 312-22. PMID 19430912 DOI: 10.1208/S12248-009-9105-4 |
0.778 |
|
| 2009 |
Fang WJ, Kulkarni SS, Murray TF, Aldrich JV. Design and synthesis of cyclic arodyn analogues by ring-closing metathesis (RCM) for kappa opioid receptor (KOP) antagonists. Advances in Experimental Medicine and Biology. 611: 279-80. PMID 19400192 DOI: 10.1007/978-0-387-73657-0_125 |
0.746 |
|
| 2009 |
Kulkarni SS, Ross NC, McLaughlin JP, Aldrich JV. Synthesis of cyclic tetrapeptide CJ 15,208: a novel kappa opioid receptor antagonist. Advances in Experimental Medicine and Biology. 611: 269-70. PMID 19400188 DOI: 10.1007/978-0-387-73657-0_121 |
0.767 |
|
| 2009 |
Dattachowdhury B, Murray TF, Aldrich JV. The synthesis of DAMGO-based potential affinity labels with high mu opioid receptor affinity and the formation of cyclic O-alkyl thiocarbamates. Advances in Experimental Medicine and Biology. 611: 265-6. PMID 19400186 DOI: 10.1007/978-0-387-73657-0_119 |
0.603 |
|
| 2009 |
Aldrich JV, Kumar V, Murray TF, Guang W, Wang JB. Dual labeled peptides as tools to study receptors: nanomolar affinity derivatives of TIPP (Tyr-Tic-Phe-Phe) containing an affinity label and biotin as probes of delta opioid receptors. Bioconjugate Chemistry. 20: 201-4. PMID 19175314 DOI: 10.1021/Bc800420T |
0.608 |
|
| 2008 |
Aldrich JV, Kumar V, Dattachowdhury B, Peck AM, Wang X, Murray TF. Solid Phase Synthesis and Application of Labeled Peptide Derivatives: Probes of Receptor-Opioid Peptide Interactions. International Journal of Peptide Research and Therapeutics. 14: 315-321. PMID 19956785 DOI: 10.1007/s10989-008-9144-1 |
0.554 |
|
| 2008 |
Charoenchai L, Wang H, Wang JB, Aldrich JV. High affinity conformationally constrained nociceptin/orphanin FQ(1-13) amide analogues. Journal of Medicinal Chemistry. 51: 4385-7. PMID 18624395 DOI: 10.1021/Jm800394V |
0.523 |
|
| 2007 |
Carey AN, Borozny K, Aldrich JV, McLaughlin JP. Reinstatement of cocaine place-conditioning prevented by the peptide kappa-opioid receptor antagonist arodyn. European Journal of Pharmacology. 569: 84-9. PMID 17568579 DOI: 10.1016/J.Ejphar.2007.05.007 |
0.716 |
|
| 2007 |
Aldrich JV. A message from the president of the American Peptide Society Biopolymers. 88: 484-484. DOI: 10.1002/Bip.20776 |
0.344 |
|
| 2005 |
Patkar KA, Yan X, Murray TF, Aldrich JV. [Nalpha-benzylTyr1,cyclo(D-Asp5,Dap8)]- dynorphin A-(1-11)NH2 cyclized in the "address" domain is a novel kappa-opioid receptor antagonist. Journal of Medicinal Chemistry. 48: 4500-3. PMID 15999987 DOI: 10.1021/Jm050105I |
0.658 |
|
| 2005 |
Marinova Z, Vukojevic V, Surcheva S, Yakovleva T, Cebers G, Pasikova N, Usynin I, Hugonin L, Fang W, Hallberg M, Hirschberg D, Bergman T, Langel U, Hauser KF, Pramanik A, ... Aldrich JV, et al. Translocation of dynorphin neuropeptides across the plasma membrane. A putative mechanism of signal transmission. The Journal of Biological Chemistry. 280: 26360-70. PMID 15894804 DOI: 10.1074/Jbc.M412494200 |
0.648 |
|
| 2005 |
Bennett MA, Murray TF, Aldrich JV. Structure-activity relationships of arodyn, a novel acetylated kappa opioid receptor antagonist. The Journal of Peptide Research : Official Journal of the American Peptide Society. 65: 322-32. PMID 15787962 DOI: 10.1111/j.1399-3011.2005.00216.x |
0.654 |
|
| 2005 |
Hauser KF, Aldrich JV, Anderson KJ, Bakalkin G, Christie MJ, Hall ED, Knapp PE, Scheff SW, Singh IN, Vissel B, Woods AS, Yakovleva T, Shippenberg TS. Pathobiology of dynorphins in trauma and disease. Frontiers in Bioscience : a Journal and Virtual Library. 10: 216-35. PMID 15574363 DOI: 10.2741/1522 |
0.552 |
|
| 2004 |
Aldrich JV, Choi H, Murray TF. An affinity label for δ-opioid receptors derived from [D-Ala 2]deltorphin I Journal of Peptide Research. 63: 108-115. PMID 15009532 DOI: 10.1111/j.1399-3011.2004.00122.x |
0.561 |
|
| 2004 |
Vig BS, Murray TF, Aldrich JV. Synthesis and opioid activity of side-chain-to-side-chain cyclic dynorphin A-(1-11) amide analogues cyclized between positions 2 and 5. 1. Substitutions in position 3. Journal of Medicinal Chemistry. 47: 446-55. PMID 14711314 DOI: 10.1021/Jm030298E |
0.714 |
|
| 2003 |
Vig BS, Murray TF, Aldrich JV. Synthesis of novel basic head-to-side-chain cyclic dynorphin A analogs: strategies and side reactions. Biopolymers. 71: 620-37. PMID 14991673 DOI: 10.1002/Bip.10591 |
0.551 |
|
| 2003 |
Choi H, Murray TF, Aldrich JV. Synthesis and evaluation of derivatives of leucine enkephalin as potential affinity labels for delta opioid receptors. Biopolymers. 71: 552-7. PMID 14635095 DOI: 10.1002/Bip.10533 |
0.65 |
|
| 2003 |
Vig BS, Zheng MQ, Murray TF, Aldrich JV. Effects of the substitution of Phe4 in the opioid peptide [D-Ala8]dynorphin A-(1-11)NH2. Journal of Medicinal Chemistry. 46: 4002-8. PMID 12954053 DOI: 10.1021/Jm030075O |
0.721 |
|
| 2003 |
Vig BS, Murray TF, Aldrich JV. A novel N-terminal cyclic dynorphin A analogue cyclo(N,5)[Trp(3),Trp(4),Glu(5)] dynorphin A-(1-11)NH(2) that lacks the basic N-terminus. Journal of Medicinal Chemistry. 46: 1279-82. PMID 12672226 DOI: 10.1021/Jm0256023 |
0.625 |
|
| 2003 |
Kumar V, Aldrich JV. A solid-phase synthetic strategy for labeled peptides: synthesis of a biotinylated derivative of the delta opioid receptor antagonist TIPP (Tyr-Tic-Phe-Phe-OH). Organic Letters. 5: 613-6. PMID 12605472 DOI: 10.1021/ol027044s |
0.47 |
|
| 2003 |
Choi H, Murray TF, Aldrich JV. Synthesis and evaluation of potential affinity labels derived from endomorphin-2 Journal of Peptide Research. 61: 58-62. PMID 12492899 DOI: 10.1034/j.1399-3011.2003.00029.x |
0.544 |
|
| 2003 |
Choi H, Murray TF, Aldrich JV. Dermorphin-based potential affinity labels for μ-opioid receptors Journal of Peptide Research. 61: 40-45. PMID 12472847 DOI: 10.1034/j.1399-3011.2003.20030.x |
0.552 |
|
| 2002 |
Bennett MA, Murray TF, Aldrich JV. Identification of arodyn, a novel acetylated dynorphin A-(1-11) analogue, as a kappa opioid receptor antagonist. Journal of Medicinal Chemistry. 45: 5617-9. PMID 12477343 DOI: 10.1021/Jm025575G |
0.686 |
|
| 2002 |
Kumar V, Murray TF, Aldrich JV. Solid phase synthesis and evaluation of Tyr-Tic-Phe-Phe(p-NHCOCH(2)Br) ([Phe(p-bromoacetamide)(4)]TIPP), a potent affinity label for delta opioid receptors. Journal of Medicinal Chemistry. 45: 3820-3. PMID 12190304 DOI: 10.1021/Jm020290P |
0.64 |
|
| 2001 |
Aldrich JV, Zheng Q, Murray TF. Dynorphin A analogs containing a conformationally constrained phenylalanine derivative in position 4: Reversal of preferred stereochemistry for opioid receptor affinity and discrimination of κ vs. δ receptors Chirality. 13: 125-129. PMID 11270320 DOI: 10.1002/1520-636X(2001)13:3<125::AID-CHIR1008>3.0.CO;2-S |
0.626 |
|
| 2000 |
Kumar V, Murray TF, Aldrich JV. Extended TIP(P) analogues as precursors for labeled δ-opioid receptor ligands Journal of Medicinal Chemistry. 43: 5050-5054. PMID 11150177 DOI: 10.1021/jm000362h |
0.536 |
|
| 2000 |
Maeda DY, Berman F, Murray TF, Aldrich JV. Synthesis and evaluation of isothiocyanate-containing derivatives of the δ-opioid receptor antagonist Tyr-Tic-Phe-Phe (TIPP) as potential affinity labels for δ-opioid receptors Journal of Medicinal Chemistry. 43: 5044-5049. PMID 11150176 DOI: 10.1021/Jm000345S |
0.677 |
|
| 2000 |
Maeda DY, Ishmael JE, Murray TF, Aldrich JV. Synthesis and evaluation of n,n-dialkyl enkephalin-based affinity labels for δ opioid receptors Journal of Medicinal Chemistry. 43: 3941-3948. PMID 11052799 DOI: 10.1021/Jm000123U |
0.588 |
|
| 2000 |
Leelasvatanakij L, Aldrich JV. A solid-phase synthetic strategy for the preparation of peptide-based affinity labels: Synthesis of dynorphin A analogs Journal of Peptide Research. 56: 80-87. PMID 10961542 DOI: 10.1034/j.1399-3011.2000.00736.x |
0.341 |
|
| 1999 |
Wan Q, Murray TF, Aldrich JV. A novel acetylated analogue of dynorphin A-(1-11) amide as a κ-opioid receptor antagonist [1] Journal of Medicinal Chemistry. 42: 3011-3013. PMID 10447942 DOI: 10.1021/jm9901071 |
0.613 |
|
| 1997 |
Soderstrom K, Choi H, Berman FW, Aldrich JV, Murray TF. N-Alkylated derivatives of [D-Pro10]dynorphin A-(1-11) are high affinity partial agonists at the cloned rat κ-opioid receptor European Journal of Pharmacology. 338: 191-197. PMID 9456002 DOI: 10.1016/S0014-2999(97)81948-6 |
0.34 |
|
| 1997 |
Choi H, Murray TF, DeLander GE, Schmidt WK, Aldrich JV. Synthesis and opioid activity of [D-Pro10]dynorphin A-(1-11) analogues with N-terminal alkyl substitution. Journal of Medicinal Chemistry. 40: 2733-9. PMID 9276018 DOI: 10.1021/Jm960747T |
0.499 |
|
| 1997 |
Arttamangkul S, Ishmael JE, Murray TF, Grandy DK, DeLander GE, Kieffer BL, Aldrich JV. Synthesis and opioid activity of conformationally constrained dynorphin A analogues. 2. Conformational constraint in the "address" sequence. Journal of Medicinal Chemistry. 40: 1211-8. PMID 9111295 DOI: 10.1021/jm960753p |
0.636 |
|
| 1995 |
Arttamangkul S, Murray TF, DeLander GE, Aldrich JV. Synthesis and opioid activity of conformationally constrained dynorphin A analogues. 1. Conformational constraint in the "message" sequence Journal of Medicinal Chemistry. 38: 2410-2417. PMID 7608905 |
0.57 |
|
| 1993 |
Choi H, Aldrich JV. Comparison of methods of the Fmoc solid-phase synthesis and cleavage of a peptide containing both tryptophan and arginine International Journal of Peptide and Protein Research. 42: 58-63. PMID 8103765 DOI: 10.1111/J.1399-3011.1993.TB00350.X |
0.314 |
|
| 1993 |
Snyder KR, Murray TF, DeLander GE, Aldrich JV. Synthesis and opioid activity of dynorphin A-(1-13)NH2 analogues containing cis- and trans-4-aminocyclohexanecarboxylic acid Journal of Medicinal Chemistry. 36: 1100-1103. PMID 8097539 DOI: 10.1021/Jm00060A018 |
0.559 |
|
| 1992 |
Choi H, Murray TF, DeLander GE, Caldwell V, Aldrich JV. N-terminal alkylated derivatives of [D-Pro10]dynorphin A-(1-11) are highly selective for κ-opioid receptors Journal of Medicinal Chemistry. 35: 4638-4639. PMID 1361580 DOI: 10.1021/Jm00102A019 |
0.626 |
|
| 1992 |
Snyder KR, Story SC, Heidt ME, Murray TF, DeLander GE, Aldrich JV. Effect of modification of the basic residues of dynorphin A-(1-13) amide on κ opioid receptor selectivity and opioid activity Journal of Medicinal Chemistry. 35: 4330-4333. PMID 1360025 DOI: 10.1021/Jm00101A010 |
0.68 |
|
| 1992 |
Story SC, Murray TF, Delander GE, Aldrich JV. Synthesis and opioid activity of 2-substituted dynorphin A-(1-13) amide analogues International Journal of Peptide and Protein Research. 40: 89-96. PMID 1359999 DOI: 10.1111/J.1399-3011.1992.TB01454.X |
0.606 |
|
| 1992 |
Story SC, Aldrich JV. Preparation of protected peptide amides using the Fmoc chemical protocol. Comparison of resins for solid phase synthesis International Journal of Peptide and Protein Research. 39: 87-92. PMID 1353068 DOI: 10.1111/J.1399-3011.1992.TB01560.X |
0.308 |
|
| Show low-probability matches. |
